20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is CHLORPROMAZINE HYDROCHLORIDE USP, with a corresponding US DMF Number 32920.
Remarkably, this DMF maintains an Active status since its submission on July 09, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 14, 2018, and payment made on June 20, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II